These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23840402)

  • 21. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
    Seksik P; Rigottier-Gois L; Gramet G; Sutren M; Pochart P; Marteau P; Jian R; Doré J
    Gut; 2003 Feb; 52(2):237-42. PubMed ID: 12524406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy.
    Dörffel Y; Swidsinski A; Loening-Baucke V; Wiedenmann B; Pavel M
    Inflamm Bowel Dis; 2012 Sep; 18(9):1663-71. PubMed ID: 22113988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings.
    Hedin CR; McCarthy NE; Louis P; Farquharson FM; McCartney S; Taylor K; Prescott NJ; Murrells T; Stagg AJ; Whelan K; Lindsay JO
    Gut; 2014 Oct; 63(10):1578-86. PubMed ID: 24398881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease.
    Collado MC; Donat E; Ribes-Koninckx C; Calabuig M; Sanz Y
    J Clin Pathol; 2009 Mar; 62(3):264-9. PubMed ID: 18996905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease].
    Ran WB; Ouyang Q; Shi W
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2884-9. PubMed ID: 24373401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    Klaassen MAY; Imhann F; Collij V; Fu J; Wijmenga C; Zhernakova A; Dijkstra G; Festen EAM; Gacesa R; Vich Vila A; Weersma RK
    J Crohns Colitis; 2019 Oct; 13(11):1439-1449. PubMed ID: 31066440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
    Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
    J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation.
    Machiels K; Pozuelo Del Río M; Martinez-De la Torre A; Xie Z; Pascal Andreu V; Sabino J; Santiago A; Campos D; Wolthuis A; D'Hoore A; De Hertogh G; Ferrante M; Manichanh C; Vermeire S
    J Crohns Colitis; 2020 Nov; 14(11):1535-1546. PubMed ID: 32333762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive compounds from regular diet and faecal microbial metabolites.
    Fernández-Navarro T; Salazar N; Gutiérrez-Díaz I; Sánchez B; Rúas-Madiedo P; de Los Reyes-Gavilán CG; Margolles A; Gueimonde M; González S
    Eur J Nutr; 2018 Mar; 57(2):487-497. PubMed ID: 27744545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.
    Fava F; Gitau R; Griffin BA; Gibson GR; Tuohy KM; Lovegrove JA
    Int J Obes (Lond); 2013 Feb; 37(2):216-23. PubMed ID: 22410962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.
    Manichanh C; Rigottier-Gois L; Bonnaud E; Gloux K; Pelletier E; Frangeul L; Nalin R; Jarrin C; Chardon P; Marteau P; Roca J; Dore J
    Gut; 2006 Feb; 55(2):205-11. PubMed ID: 16188921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.
    Walton C; Montoya MP; Fowler DP; Turner C; Jia W; Whitehead RN; Griffiths L; Waring RH; Ramsden DB; Cole JA; Cauchi M; Bessant C; Naylor SJ; Hunter JO
    Eur J Clin Nutr; 2016 Sep; 70(9):1052-6. PubMed ID: 27167669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two distinct metacommunities characterize the gut microbiota in Crohn's disease patients.
    He Q; Gao Y; Jie Z; Yu X; Laursen JM; Xiao L; Li Y; Li L; Zhang F; Feng Q; Li X; Yu J; Liu C; Lan P; Yan T; Liu X; Xu X; Yang H; Wang J; Madsen L; Brix S; Wang J; Kristiansen K; Jia H
    Gigascience; 2017 Jul; 6(7):1-11. PubMed ID: 28655159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
    He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
    Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
    Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
    J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
    Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
    Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.